It was not so long ago when Valsartan manufacturers started ...
Read More That pesky NDMA is causing problems again now with Ranitidine
Native Mass Spectrometry Accelerates Biopharmaceutical Drug Deve...
It wasnât so long ago that native mass spectrometry was...
Read More Native Mass Spectrometry Accelerates Biopharmaceutical Drug Development
MAM Adds Consistency and Reliability to Biopharmaceutical QC
Eating food is necessary to keep ourselves healthy and alive...
Read More MAM Adds Consistency and Reliability to Biopharmaceutical QC
Quality by Design: Understanding How to Develop and Make Better ...
Iâm a planner by nature and as a full-time working mum ...
Read More Quality by Design: Understanding How to Develop and Make Better Biologics
5 Ways to Become a Biopharma MAM Master
More Than Monitoring The Multi-Attribute Method (MAM) for st...
Read More 5 Ways to Become a Biopharma MAM Master
Fucose Matters in Biotherapeutics Production
I would like to talk about fucose. âFucoseâ¦is that...
Read More Fucose Matters in Biotherapeutics Production
TOF vs. Orbitrap for Intact Protein Structural Insights
The analysis of intact proteins, such as therapeutic monoclo...
Read More TOF vs. Orbitrap for Intact Protein Structural Insights
Using Mass Spectrometry for Oligonucleotide and Peptides Synthes...
Synthetic oligonucleotides and peptides are frequently used ...
Read More Using Mass Spectrometry for Oligonucleotide and Peptides Synthesis Assessment
Why Does the Monoclonal Antibody Make Such an Ideal Biotherapeut...
If you review any charts of the top 10-20 selling drugs over...
Read More Why Does the Monoclonal Antibody Make Such an Ideal Biotherapeutic?
Six Glycan Analysis Strategies for Biotherapeutics
Glycosylation is one of the most common protein post-transla...
Read More Six Glycan Analysis Strategies for Biotherapeutics